cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension ...
CGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension ...
Source: pr-inside.com
Page 16 - Lexaria Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lexaria Bioscience Today - Breaking & Trending Today
Lexaria Bioscience Announces Closing of $2.0 Million Public Offering
Lexaria Bioscience Announces Closing of $2.0 Million Public Offering
Source: pr-inside.com
Lexaria Bioscience Corp.: Lexaria Bioscience Announces Closing of $2.0 Million Public Offering
KELOWNA, BC / ACCESSWIRE / May 11, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the closing of
Source: finanznachrichten.de
Lexaria Bioscience Corp.: cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension Clinical Trial
DehydraTECH-CBD is currently unique in its evidenced superior power to reduce blood pressure over other oral CBD formulations.DehydraTECH-CBD has demonstrated exceptional safety and tolerability and a
Source: finanznachrichten.de
Lexaria Bioscience Corp.: Lexaria Announces 2023 Annual Meeting Results
KELOWNA, BC / ACCESSWIRE / May 10, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the results of the 2023
Source: finanznachrichten.de